Back to News
Market Impact: 0.35
Medtronic Boosts FY27 Outlook; Stock Up 4.7%
Source: Nasdaq
Corporate EarningsCorporate Guidance & OutlookCompany Fundamentals
Medtronic raised its full-year 2027 adjusted earnings and organic revenue growth guidance while reporting Q1 results. The upgrade signals improved demand/visibility versus prior assumptions, which is likely to be supportive for MDT sentiment and near-term expectations.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
MDT0.55
More News
- The IPO drought is driving private equity-owned companies to the debt market to pay investors
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- FDA approves Enspryng for thyroid eye disease treatment
- Giant Taiwanese chipmaker TSMC confirms it’s in talks with Elon Musk to join ‘Terafab’ complex in Texas: ‘The AI market continues to be very strong’
- The Tesla Roadster 2 Is Here—and It Flies
- Suddenly, Wall Street is worried that the U.S. economy is more ‘vulnerable’ than it looks
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Research Systems for Hedge Funds: A Pilot Design
- Weekly Update: New Reporting Features, UI Improvements, and Chat Optimizations